Locations
Lyngby, Denmark · 2970 Hørsholm, Denmark
industry
Health · Medical Devices
Size
11-50 employees
Stage
Other
founded in
2015
Medtrace is striving to minimize diagnostic uncertainty through better perfusion imaging. Perfusion imaging provides medical professionals with a functional understanding of the organs' blood supply inside the patient. Medtrace is developing a solution that will help healthcare providers diagnose patients more accurately and quickly. Our solution allows for absolute blood flow quantification based upon the PET tracer 15O-water, which has long been acknowledged as the gold standard tracer for non-invasive blood flow quantification. Our innovative solution is intended to make 15O-water practically available right next to the PET scanner connected to an onsite cyclotron, with a software package to quantify the myocardial blood flow and perfusion. Important notice: Medtrace’s products are not currently cleared for routine use in any markets, including both the US and Europe. In the US, 15O-water is currently under investigation as an investigational drug in a phase 3 clinical trial.
Something looks off?On-site & Remote